Skip to content
Screener

Delcath Systems DCTH Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$29.1MBeat by $2.9M
EPS$0.07Beat by $0.16
Revenue estimate$26.3M
EPS estimate-$0.09
“Our strong second quarter, including total revenue of $29.1 million and quarterly operating cash flow of $5.7 million, reflects continued momentum in HEPZATO procedures. As we grow our active treatment center network and drive physician adoption, we are seeing increased usage of HEPZATO in combination with systemic therapies to treat metastatic uveal melanoma. The growing clinical experience with this treatment strategy is strengthening physician confidence in HEPZATO and supporting its development as a multi-indication, liver-directed therapy platform, including colorectal and breast cancer.”
Gerard Michel

Next report

Nov 3, 2026 (in a month)
Revenue estimate$26.0M
EPS estimate-$0.10

Financials

Q2 2026

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$534.71M+43.5%
Enterprise value$489.67M+47.6%
P/E104.3×—
P/S5.6×+0.9×

Profitability

See full
Gross margin87.1%+1.2pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio9.8×-1.0×

Segments

By product

See full
HEPZATO KIT$27.2M+20.7%
CHEMOSAT$2.0M+19.1%

By geography

See full
Foreign$2.0M+19.1%

FAQ

When did Delcath Systems report Q2 2026 earnings?
Delcath Systems (DCTH) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Delcath Systems's Q2 2026 revenue and EPS?
Delcath Systems reported revenue of $29.1M and eps of $0.07 for Q2 2026.
Did Delcath Systems beat estimates in Q2 2026?
Revenue beat the consensus estimate of $26.3M by $2.9M. EPS beat the consensus estimate of $-0.09 by $0.16.
How did Delcath Systems's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 20.6% from $24.2M a year earlier and eps grew 0.0% from $0.07.
Where can I find Delcath Systems's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-053902) and the 10-Q periodic report (0001628280-26-053956) directly on SEC EDGAR. The filing index links above go to sec.gov.